✦ LIBER ✦

Serum CA 125 level as a reflection of proliferative activity of serous borderline ovarian tumor

✍ Scribed by I But

Book ID: 117123108
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 75 KB
Volume: 71
Category: Article
ISSN: 0020-7292
DOI: 10.1016/s0020-7292(00)00331-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum CA-125 as a marker of disease acti

Serum CA-125 as a marker of disease activity in uterine papillary serous carcinoma

✍ Drew Abramovich; Maurie Markman; Alexander Kennedy; Kenneth Webster; Jerome Beli 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 48 KB

Preoperative Value of CA 125 as a Reflec

Preoperative Value of CA 125 as a Reflection of Tumor Grade in Epithelial Ovarian Cancer

✍ Igor But; Borut Gorišek 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Significance of serum CA-125 level as a

Significance of serum CA-125 level as a prognostic factor after the first cycle of chemotherapy in patients with advanced serous epithelial ovarian cancer

✍ Kim, S.; Chang, M.Y.; Chay, D.B.; Cho, H.; Kim, Y.T.; Kim, J.H. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Ovarian carcinoma serum markers and ovar

Ovarian carcinoma serum markers and ovarian steroid activity — is there a link in ovarian cancer? A correlation of inhibin, tetranectin and CA-125 to ovarian activity and the gonadotropin levels

✍ Jan Blaakaer; Claus Kim Høgdall; Snezana Micic; Kim Toftager-Larsen; Ulla Hørdin 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 390 KB

Pretreatment serum levels of CA-125, car

Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: Relevance for differential diagnosis

✍ Bengt Tholander; Adam Taube; Anders Lindgren; Olof Sjöberg; Ulf Stendahl; Arvo K 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 963 KB

Association between serum levels of solu

Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy : A Gynecologic Oncology Group study

✍ Robert A. Burger; Kathleen M. Darcy; Philip J. DiSaia; Bradley J. Monk; Elizabet 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

## Abstract ## BACKGROUND A prospective study was undertaken within the Gynecologic Oncology Group to determine whether serum levels of soluble tumor necrosis factor receptors I (sTNFR‐I) and II (sTNFR‐II), alone or in combination with CA 125, were associated with clinicopathologic characteristics